Groowe Groowe / Newsroom / ALVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ALVO News

Alvotech Ordinary Shares

Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update

globenewswire.com
ALVO

Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update

globenewswire.com
ALVO

Alvotech to Present at Upcoming Investor Conferences in November

globenewswire.com
ALVO

Alvotech to Present at Upcoming Investor Conferences in November

globenewswire.com
ALVO

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

globenewswire.com
ALVO

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

globenewswire.com
ALVO

Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch

globenewswire.com
ALVO

Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch

globenewswire.com
ALVO

Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

globenewswire.com
ALVO REGN

Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

globenewswire.com
ALVO